Up-front resection for hepatocellular carcinoma: Assessing futility in the preoperative setting.
作者信息
Altaf Abdullah, Khalil Mujtaba, Akabane Miho, Rashid Zayed, Kawashima Jun, Zindani Shahzaib, Ruzzenente Andrea, Ratti Francesca, Marques Hugo, Cauchy François, Lam Vincent, Poultsides George, Aucejo Federico, Kitago Minoru, Popescu Irinel, Martel Guillaume, Gleisner Ana, Bauer Todd W, Hugh Tom, Bhimani Nazim, Shen Feng, Endo Itaru, Pawlik Timothy M
机构信息
Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, United States.
Department of Surgery, University of Verona, Verona, Italy.
出版信息
Eur J Surg Oncol. 2025 May;51(5):109594. doi: 10.1016/j.ejso.2025.109594. Epub 2025 Jan 10.
OBJECTIVE
We sought to develop a predictive model to preoperatively identify patients with hepatocellular carcinoma (HCC) at risk of undergoing futile upfront liver resection (LR).
METHODS
Patients undergoing curative-intent LR for HCC were identified from a large multi-institutional database. Futile LR was defined by death or disease recurrence within six months postoperatively. Backward logistic regression was performed to identify factors associated with futility. Additionally, binary criteria were established for surgical candidacy, aiming to keep the likelihood of futility below 20 %.
RESULTS
Among 1633 patients with HCC, 264 (16.2 %) underwent futile upfront LR. Tumor burden score (TBS) (coefficient: 0.083, 95%CI: 0.067-0.099), alpha-fetoprotein (AFP) (coefficient: 0.254, 95%CI: 0.195-0.310), and albumin-bilirubin (ALBI) grade 2/3 (coefficient: 0.566, 95%CI: 0.420-0.718) were independently associated with an increased risk of futile LR. The model demonstrated strong discrimination and calibration in both derivation and validation cohorts. Low, intermediate, and high-risk groups were determined based on the risk model, each with an escalating likelihood of futility, worse histological features, and worse survival outcomes. Six distinct conditions based on AFP-adjusted-to-TBS criteria were established, all with a futility likelihood of less than 20 %. Patients fulfilling these criteria had significantly better long-term recurrence-free and overall survival. The futility risk model was made available online for wide clinical applicability: (https://altaf-pawlik-hcc-futilityofsurgery-calculator.streamlit.app/).
CONCLUSION
A preoperative risk model and AFP-adjusted-to-TBS criteria were developed and validated to predict the likelihood of futile LR among patients with HCC. This pragmatic clinical tool may assist clinicians in preoperative decision-making, helping them avoid futile surgery unlikely to offer long-term benefits.
Zotero 插件